In univariate analysis, older age (≥ 64 years) and lower percentage MAF (< 0.6%) were significantly associated with improved OS, while fewer than three lines of prior chemotherapy showed a trend toward improved survival (Table 3 ).
← all excerpts
Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients.
1
—
—